Validation of Patient-Reported Outcomes in the On-Demand Treatment of Hereditary Angioedema Attacks Published in Clinical Reviews in Allergy & Immunology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/3/2026

1. SPY
2. TSLA
3. META
4. STZ
5. INTC
6. HOOD
7. SPCX
8. GOOGL
9. FDS
10. FUTU

Go back to Validation of Patient-Reported Outcomes in the On-Demand Treatment of Hereditary Angioedema Attacks Published in Clinical Reviews in Allergy & Immunology
(NASDAQ: PHVS) Delayed: 33.86 -0.09 (0.27%)
Previous Close $33.95    52 Week High $ 
Open $34.37    52 Week Low $ 
Day High $34.77    P/E N/A 
Day Low $33.16    EPS $ 
Volume 478,099